- Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man2007 | Publication without faculty affiliation
- Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man2007 | Faculty of Pharmacy in Hradec Králové
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C32008 | Central Library of Charles University
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C32008 | Faculty of Pharmacy in Hradec Králové
- AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids2009 | Central Library of Charles University
- Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases2016 | Faculty of Pharmacy in Hradec Králové
- Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment2018 | Faculty of Pharmacy in Hradec Králové
- Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile2018 | Faculty of Pharmacy in Hradec Králové
- The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients2014 | First Faculty of Medicine, Second Faculty of Medicine